These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 24004647)

  • 1. Prognostic determinants in patients with uterine and ovarian clear cell carcinoma: a SEER analysis.
    Rauh-Hain JA; Davis M; Clemmer J; Clark RM; Growdon WB; Goodman AK; Boruta DM; Schorge JO; del Carmen MG
    Gynecol Oncol; 2013 Nov; 131(2):404-9. PubMed ID: 24004647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic determinants in patients with uterine and ovarian clear carcinoma.
    Rauh-Hain JA; Winograd D; Growdon WB; Schorge JO; Goodman AK; Boruta DM; Berkowitz RS; Horowitz NS; Del Carmen MG
    Gynecol Oncol; 2012 May; 125(2):376-80. PubMed ID: 22366593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carcinosarcoma of the ovary compared to papillary serous ovarian carcinoma: a SEER analysis.
    Rauh-Hain JA; Diver EJ; Clemmer JT; Bradford LS; Clark RM; Growdon WB; Goodman AK; Boruta DM; Schorge JO; del Carmen MG
    Gynecol Oncol; 2013 Oct; 131(1):46-51. PubMed ID: 23906658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers.
    Chan JK; Teoh D; Hu JM; Shin JY; Osann K; Kapp DS
    Gynecol Oncol; 2008 Jun; 109(3):370-6. PubMed ID: 18395777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian cancer in younger vs older women: a population-based analysis.
    Chan JK; Urban R; Cheung MK; Osann K; Shin JY; Husain A; Teng NN; Kapp DS; Berek JS; Leiserowitz GS
    Br J Cancer; 2006 Nov; 95(10):1314-20. PubMed ID: 17088903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors and treatment outcomes for patients with surgically staged uterine clear cell carcinoma focusing on the early stage: A Taiwanese Gynecologic Oncology Group study.
    Hsu KF; Chou HH; Huang CY; Fu HC; Chiang AJ; Tsai HW; Chen JR; Cheng WF; Ke YM; Chang CC; Chen TH; Lin SH; Ho CM
    Gynecol Oncol; 2014 Sep; 134(3):516-22. PubMed ID: 25019570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in demographic and clinical characteristics in women diagnosed with corpus cancer and their potential impact on the increasing number of deaths.
    Ueda SM; Kapp DS; Cheung MK; Shin JY; Osann K; Husain A; Teng NN; Berek JS; Chan JK
    Am J Obstet Gynecol; 2008 Feb; 198(2):218.e1-6. PubMed ID: 18226630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is the presence of endometriosis associated with a survival benefit in pure ovarian clear cell carcinoma?
    Sahin H; Sari ME; Cuylan ZF; Haberal AN; Sirvan L; Coban G; Yalcin I; Güngör T; Celik H; Meydanli MM; Ayhan A
    Arch Gynecol Obstet; 2018 Apr; 297(4):1005-1013. PubMed ID: 29383437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Venous thromboembolism during primary treatment of ovarian clear cell carcinoma is associated with decreased survival.
    Diaz ES; Walts AE; Karlan BY; Walsh CS
    Gynecol Oncol; 2013 Dec; 131(3):541-5. PubMed ID: 24041880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and prognostic impact of lymphadenectomy and lymph node metastasis in clinically early-stage ovarian clear cell carcinoma.
    Mahdi H; Moslemi-Kebria M; Levinson KL; Gojayev A; Lockhart D; Ali-Fehmi R; Munkarah AR
    Int J Gynecol Cancer; 2013 Sep; 23(7):1226-30. PubMed ID: 23736258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of Care, Predictors, and Outcomes of Adjuvant Therapy for Early- and Advanced-Stage Uterine Clear Cell Carcinoma: A Population-Based Analysis.
    Gockley AA; Rauh-Hain JA; Anders AM; Meyer LA; Clemmer J; Lu KH; Clark RM; Schorge JO; del Carmen MG
    Int J Gynecol Cancer; 2016 May; 26(4):697-704. PubMed ID: 26825834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic nomogram for predicting the overall survival rate of patients with uterine clear-cell carcinoma: Based on SEER database.
    Huang T; Lu F
    Int J Gynaecol Obstet; 2024 Aug; 166(2):707-717. PubMed ID: 38444201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathologic features and treatment in patients with early stage uterine clear cell carcinoma: A 16-year experience.
    Armbruster SD; Previs R; Soliman PT; Westin SN; Fellman B; Jhingran A; Fleming ND
    Gynecol Oncol; 2019 Aug; 154(2):328-332. PubMed ID: 31221496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploration and prognostic analysis of two types of high-risk ovarian cancers: clear cell vs. serous carcinoma: a population-based study.
    Liu T; Gao Y; Li S; Xu S
    J Ovarian Res; 2024 Jun; 17(1):119. PubMed ID: 38824600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The elevated risk of ovarian clear cell carcinoma among Asian Pacific Islander women in the United States is not affected by birthplace.
    Korenaga TR; Ward KK; Saenz C; McHale MT; Plaxe S
    Gynecol Oncol; 2020 Apr; 157(1):62-66. PubMed ID: 32008796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant chemotherapy in patients with stage I endometrioid or clear cell ovarian cancer in the platinum era: a Surveillance, Epidemiology, and End Results Cohort Study, 2000-2013.
    Oseledchyk A; Leitao MM; Konner J; O'Cearbhaill RE; Zamarin D; Sonoda Y; Gardner GJ; Long Roche K; Aghajanian CA; Grisham RN; Brown CL; Snyder A; Chi DS; Soslow RA; Abu-Rustum NR; Zivanovic O
    Ann Oncol; 2017 Dec; 28(12):2985-2993. PubMed ID: 28950307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic impact of lymphadenectomy in uterine clear cell carcinoma.
    Mahdi H; Lockhart D; Moselmi-Kebria M
    J Gynecol Oncol; 2015 Apr; 26(2):134-40. PubMed ID: 25686398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Could fertility-sparing surgery be considered for women with early stage ovarian clear cell carcinoma?
    Nasioudis D; Chapman-Davis E; Frey MK; Witkin SS; Holcomb K
    J Gynecol Oncol; 2017 Nov; 28(6):e71. PubMed ID: 28758377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statin treatment is associated with survival in a nationally representative population of elderly women with epithelial ovarian cancer.
    Vogel TJ; Goodman MT; Li AJ; Jeon CY
    Gynecol Oncol; 2017 Aug; 146(2):340-345. PubMed ID: 28596017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic determinants in patients with uterine and ovarian carcinosarcoma.
    Rauh-Hain JA; Shoni M; Schorge JO; Goodman A; Horowitz NS; del Carmen MG
    J Reprod Med; 2013; 58(7-8):297-304. PubMed ID: 23947079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.